Healthcare provider profile · identity verified

Larry D. Brown, M.D.

Allopathic & Osteopathic Physicians|Family Medicine · JASPER, TX · NPI 1942276605

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Larry D. Brown, M.D. received $119.32 in general payments during 2025 across 6 reported records.

Novo Nordisk Inc accounted for 30.8% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 7 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rexulti, Rybelsus.

Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Rexulti by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 164 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Rybelsus by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$119.32

6 reported records · 5 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$36.70	30.8%	2	2025
Tactile Systems Technology Inc	Unresolved — no canonical attribution shown	$35.39	29.7%	1	2025
Dexcom, Inc.	Unresolved — no canonical attribution shown	$18.25	15.3%	1	2025
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	Unresolved — no canonical attribution shown	$15.13	12.7%	1	2025
Lundbeck LLC	Unresolved — no canonical attribution shown	$13.85	11.6%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$119.32	6

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$36.70	2	2025
Source payment records 2025-03-24 · Novo Nordisk Inc · $21.18 · Open Payments source 2025-10-07 · Novo Nordisk Inc · $15.52 · Open Payments source
Flexitouch Plus Normalized: flexitouch plus	Device	Tactile Systems Technology Inc	$35.39	1	2025
Source payment records 2025-11-25 · Tactile Systems Technology Inc · $35.39 · Open Payments source
Nimbl Normalized: nimbl	Device	Tactile Systems Technology Inc	$35.39	1	2025
Source payment records 2025-11-25 · Tactile Systems Technology Inc · $35.39 · Open Payments source
Rybelsus Normalized: rybelsus	Drug	Novo Nordisk Inc	$21.18	1	2025
Source payment records 2025-03-24 · Novo Nordisk Inc · $21.18 · Open Payments source
Dexcom G6 Transmitter Normalized: dexcom g6 transmitter	Medical Supply	Dexcom, Inc.	$18.25	1	2025
Source payment records 2025-10-27 · Dexcom, Inc. · $18.25 · Open Payments source
CAPLYTA Normalized: caplyta	Drug	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$15.13	1	2025
Source payment records 2025-10-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $15.13 · Open Payments source
REXULTI Normalized: rexulti	Drug	Lundbeck LLC	$13.85	1	2025
Source payment records 2025-11-03 · Lundbeck LLC · $13.85 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
Ozempic ozempic	2025	Ozempic	2024	164	exact normalized	Medicare Part D
REXULTI rexulti	2025	Rexulti	2024	30 Beneficiary count suppressed	exact normalized	Medicare Part D
Rybelsus rybelsus	2025	Rybelsus	2024	20 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lundbeck LLC Exact reporting entity; no affiliate inference	2025	REXULTI open payments reported associated product	CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986	Rexulti · 2024 Exact normalized brand match · 1 Part D row	30	suppressed by CMS
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	164	32
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	20	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	816	217
Amlodipine Besylate	Amlodipine Besylate	635	155
Gabapentin	Gabapentin	560	151
Furosemide	Furosemide	535	147
Losartan Potassium	Losartan Potassium	530	133
Metoprolol Succinate	Metoprolol Succinate	435	97
Levothyroxine Sodium	Levothyroxine Sodium	430	114
Pantoprazole Sodium	Pantoprazole Sodium	381	101
Metformin Hcl	Metformin Hcl	344	92
Potassium Chloride	Potassium Chloride	328	90
Lisinopril	Lisinopril	323	96
Tamsulosin Hcl	Tamsulosin Hcl	315	77
Allopurinol	Allopurinol	290	68
Clopidogrel	Clopidogrel Bisulfate	264	69
Omeprazole	Omeprazole	258	64
Montelukast Sodium	Montelukast Sodium	254	64
Albuterol Sulfate Hfa	Albuterol Sulfate	244	78
Meloxicam	Meloxicam	237	88
Hydrochlorothiazide	Hydrochlorothiazide	236	68
Rosuvastatin Calcium	Rosuvastatin Calcium	234	66
Simvastatin	Simvastatin	233	56
Tizanidine Hcl	Tizanidine Hcl	224	58
Carvedilol	Carvedilol	209	64
Sertraline Hcl	Sertraline Hcl	209	42
Citalopram Hbr	Citalopram Hydrobromide	192	59
Metoprolol Tartrate	Metoprolol Tartrate	180	51
Pioglitazone Hcl	Pioglitazone Hcl	180	39
Famotidine	Famotidine	165	43
Ozempic	Semaglutide	164	32
Glimepiride	Glimepiride	158	38
Buspirone Hcl	Buspirone Hcl	157	36
Alprazolam	Alprazolam	144	35
Eliquis	Apixaban	142	40
Nifedipine Er	Nifedipine	135	33
Trazodone Hcl	Trazodone Hcl	132	34
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	131	35
Tramadol Hcl	Tramadol Hcl	120	50
Duloxetine Hcl	Duloxetine Hcl	115	28
Glipizide	Glipizide	113	26
Escitalopram Oxalate	Escitalopram Oxalate	111	29
Farxiga	Dapagliflozin Propanediol	108	26
Hydralazine Hcl	Hydralazine Hcl	103	36
Ibuprofen	Ibuprofen	103	40
Ezetimibe	Ezetimibe	99	24
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	98	77
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	94	24
Isosorbide Mononitrate Er	Isosorbide Mononitrate	92	18
Fluoxetine Hcl	Fluoxetine Hcl	91	21
Diclofenac Sodium	Diclofenac Sodium	89	31
Januvia	Sitagliptin Phosphate	87	15
Mirtazapine	Mirtazapine	87	24
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	87	24
Clonidine Hcl	Clonidine Hcl	86	21
Esomeprazole Magnesium	Esomeprazole Magnesium	85	26
Finasteride	Finasteride	84	19
Doxepin Hcl	Doxepin Hcl	81	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	78	30
Levetiracetam	Levetiracetam	77	23
Quetiapine Fumarate	Quetiapine Fumarate	77	15
Fluticasone Propionate	Fluticasone Propionate	76	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	75	23
Donepezil Hcl	Donepezil Hcl	74	27
Fenofibrate	Fenofibrate Nanocrystallized	74	17
Spironolactone	Spironolactone	73	19
Amiodarone Hcl	Amiodarone Hcl	70	15
Linzess	Linaclotide	70	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	69	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	18
Memantine Hcl	Memantine Hcl	66	20
Myrbetriq	Mirabegron	66	14
Celecoxib	Celecoxib	64	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	64	47
Pregabalin	Pregabalin	64	13
Jardiance	Empagliflozin	63	16
Oxybutynin Chloride Er	Oxybutynin Chloride	62	11
Hydroxyzine Hcl	Hydroxyzine Hcl	61	25
Olmesartan Medoxomil	Olmesartan Medoxomil	61	12
Ropinirole Hcl	Ropinirole Hcl	61	14
Xarelto	Rivaroxaban	59	19
Naproxen	Naproxen	58	26
Zolpidem Tartrate	Zolpidem Tartrate	58	13
Triamcinolone Acetonide	Triamcinolone Acetonide	57	28
Clonazepam	Clonazepam	56	suppressed
Trulicity	Dulaglutide	55	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	53	44
Methocarbamol	Methocarbamol	53	13
Estradiol	Estradiol	51	suppressed
Azithromycin	Azithromycin	50	46
Azelastine Hcl	Azelastine Hcl	49	33
Prednisone	Prednisone	49	29
Cilostazol	Cilostazol	47	11
Benazepril Hcl	Benazepril Hcl	46	suppressed
Latanoprost	Latanoprost	46	suppressed
Propranolol Hcl	Propranolol Hcl	46	14
Metformin Hcl Er	Metformin Hcl	45	11
Ondansetron Hcl	Ondansetron Hcl	45	29
Sucralfate	Sucralfate	45	11
Amitriptyline Hcl	Amitriptyline Hcl	43	16
Pravastatin Sodium	Pravastatin Sodium	43	15
Meclizine Hcl	Meclizine Hcl	42	16
Telmisartan	Telmisartan	42	12
Baclofen	Baclofen	41	11
Alendronate Sodium	Alendronate Sodium	40	13
Synthroid	Levothyroxine Sodium	40	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	39	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	39	15
Acetaminophen-Codeine	Acetaminophen With Codeine	38	11
Divalproex Sodium	Divalproex Sodium	38	suppressed
Ranolazine Er	Ranolazine	38	suppressed
Fluconazole	Fluconazole	37	24
Lactulose	Lactulose	37	15
Testosterone Cypionate	Testosterone Cypionate	36	suppressed
Tresiba Flextouch U-100	Insulin Degludec	36	suppressed
Levofloxacin	Levofloxacin	33	27
Risperidone	Risperidone	33	suppressed
Topiramate	Topiramate	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	12
Isosorbide Dinitrate	Isosorbide Dinitrate	32	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	31	suppressed
Aripiprazole	Aripiprazole	30	suppressed
Atenolol	Atenolol	30	suppressed
Bupropion Hcl	Bupropion Hcl	30	suppressed
Divalproex Sodium Er	Divalproex Sodium	30	suppressed
Lidocaine	Lidocaine	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Nateglinide	Nateglinide	30	suppressed
Rexulti	Brexpiprazole	30	suppressed
Bumetanide	Bumetanide	29	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	29	suppressed
Glipizide Er	Glipizide	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	11
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	11
Chlorthalidone	Chlorthalidone	26	suppressed
Dexlansoprazole Dr	Dexlansoprazole	26	suppressed
Entresto	Sacubitril/Valsartan	26	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	26	suppressed
Nitroglycerin	Nitroglycerin	26	18
Nabumetone	Nabumetone	25	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	24	12
Dicyclomine Hcl	Dicyclomine Hcl	24	11
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	16
Premarin	Estrogens, Conjugated	24	suppressed
Valsartan	Valsartan	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Mometasone Furoate	Mometasone Furoate	22	11
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	12
Risedronate Sodium	Risedronate Sodium	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Humalog Mix 50-50 Kwikpen	Insulin Lispro Protamin/Lispro	21	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	21	suppressed
Nystatin	Nystatin	21	15
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Colchicine	Colchicine	20	suppressed
Dexamethasone	Dexamethasone	20	18
Janumet Xr	Sitagliptin Phos/Metformin Hcl	20	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Rybelsus	Semaglutide	20	suppressed
Tresiba Flextouch U-200	Insulin Degludec	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Benztropine Mesylate	Benztropine Mesylate	19	suppressed
Cefdinir	Cefdinir	19	18
Cephalexin	Cephalexin	19	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Primidone	Primidone	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Constulose	Lactulose	18	suppressed
Torsemide	Torsemide	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Calcitriol	Calcitriol	17	suppressed
Carbamazepine	Carbamazepine	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Metronidazole	Metronidazole	17	15
Oxcarbazepine	Oxcarbazepine	17	suppressed
Praluent Pen	Alirocumab	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Dapagliflozin	Dapagliflozin Propanediol	15	suppressed
Digoxin	Digoxin	15	suppressed
Invokamet	Canagliflozin/Metformin Hcl	15	suppressed
Methimazole	Methimazole	15	suppressed
Novolin R	Insulin Regular, Human	15	suppressed
Rivastigmine	Rivastigmine Tartrate	15	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	12
Labetalol Hcl	Labetalol Hcl	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nexium	Esomeprazole Magnesium	14	suppressed
Nexletol	Bempedoic Acid	14	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Progesterone	Progesterone, Micronized	14	suppressed
Sulfasalazine	Sulfasalazine	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Trintellix	Vortioxetine Hydrobromide	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Zonisamide	Zonisamide	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	13	suppressed
Armour Thyroid	Thyroid,pork	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Glyburide	Glyburide	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Paliperidone Er	Paliperidone	12	suppressed
Penicillin V Potassium	Penicillin V Potassium	12	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Ibu	Ibuprofen	11	suppressed
Indapamide	Indapamide	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Probenecid	Probenecid	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Vilazodone Hcl	Vilazodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$119.32 · 6 records	Novo Nordisk Inc	CAPLYTA, Dexcom G6 Transmitter, Flexitouch Plus, Nimbl, Ozempic, REXULTI, Rybelsus	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Ozempic play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Lundbeck LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error